Patent ductus arteriosus treated with ligation or indomethacin: a follow-up study.
J Pediatr
; 95(4): 588-91, 1979 Oct.
Article
em En
| MEDLINE
| ID: mdl-480040
The course and complications of fifty-two infants with patent ductus arteriosus requiring closure were assessed prospectively. Twenty-six infants with a PDA received indomethacin for pharmacologic closure of the PDA, and 26 underwent ligation. The current study analyzes and compares the longitudinal follow-up with respect to somatic growth, neurologic function, psychomotor and mental development, and renal, ophthalmologic, and audiologic function in 21 infants in each group who entered the follow-up. No selective morbidity was attributable to PDA closure with indomethacin when compared to surgically treated infants.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Indometacina
/
Permeabilidade do Canal Arterial
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
Aspecto:
Patient_preference
Limite:
Humans
/
Infant
/
Newborn
Idioma:
En
Revista:
J Pediatr
Ano de publicação:
1979
Tipo de documento:
Article
País de publicação:
Estados Unidos